Anxiety epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
| Line 21: | Line 21: | ||
*[Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name]. | *[Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name]. | ||
===Gender=== | ===Gender=== | ||
*[ | * [[Anxiety]] is more prevalent in females than in males. The male to female ratio is approximately 3 to 1.<ref name="pmid15939839">{{cite journal |vauthors=Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE |title=Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication |journal=Arch. Gen. Psychiatry |volume=62 |issue=6 |pages=617–27 |year=2005 |pmid=15939839 |pmc=2847357 |doi=10.1001/archpsyc.62.6.617 |url=}}</ref> | ||
===Region=== | ===Region=== | ||
*The majority of [disease name] cases are reported in [geographical region]. | *The majority of [disease name] cases are reported in [geographical region]. | ||
Revision as of 14:41, 21 August 2017
|
Anxiety Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Anxiety epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Anxiety epidemiology and demographics |
|
Risk calculators and risk factors for Anxiety epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Epidemiology and Demographics
Prevalence
The prevalence of anxiety disorders is estimated to 18000 per 100,000 (18%) individuals[1]
Age
- Patients of all age groups may develop [disease name].
- The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
- [Disease name] commonly affects individuals younger than/older than [number of years] years of age.
- [Chronic disease name] is usually first diagnosed among [age group].
- [Acute disease name] commonly affects [age group].
Race
- There is no racial predilection to [disease name].
- [Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].
Gender
- Anxiety is more prevalent in females than in males. The male to female ratio is approximately 3 to 1.[2]
Region
- The majority of [disease name] cases are reported in [geographical region].
- [Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].
Developed Countries
Developing Countries
References
- ↑ Wang PS, Lane M, Olfson M, Pincus HA, Wells KB, Kessler RC (2005). "Twelve-month use of mental health services in the United States: results from the National Comorbidity Survey Replication". Arch. Gen. Psychiatry. 62 (6): 629–40. doi:10.1001/archpsyc.62.6.629. PMID 15939840.
- ↑ Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE (2005). "Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication". Arch. Gen. Psychiatry. 62 (6): 617–27. doi:10.1001/archpsyc.62.6.617. PMC 2847357. PMID 15939839.